Key result
Infantile-onset spinal muscular atrophy was associated with 54.2 times higher total healthcare costs compared to matched non-SMA controls, averaging $25,517 per month.
Why the study?
Treatment patterns, healthcare resource utilization, and costs of care among patients with spinal muscular atrophy were not well understood.
Cohort (n=682)
Answers are grounded in this paper and cite their sources.
Patients with spinal muscular atrophy, particularly those with infantile onset, experience significantly higher healthcare utilization, costs, and mortality compared to the general population.
OBJECTIVES: To understand treatment patterns, healthcare resource utilization, and costs of care among patients with spinal muscular atrophy (SMA). Methods: SMA patients were identified from a large managed care population using administrative claims data from January 2006 to March 2016. Patients were classified into infantile, childhood-onset, and late-onset groups based on age of first SMA diagnosis. They were matched 1:1 to non-SMA patients based on age, gender, geography, and health plan type. RESULTS: In the infantile group, 17.4% and 26.1% were treated with invasive and non-invasive ventilation, respectively. Uses of orthotics/orthoses and orthopedic surgery were frequent: 54.5% and 22.7% childhood group; 27.0% and 38.5% late-onset group. Mean per member per month costs in SMA vs. matched non-SMA patients was $25,517 vs. $406 (infantile); $6,357 vs. $188 (childhood-onset); $2,499 vs. $742 (late-onset). CONCLUSIONS: SMA patients, particularly with infantile onset, incurred significantly higher healthcare utilization and costs than the general population.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2019) conducted a cohort in Spinal Muscular Atrophy (n=682). Spinal Muscular Atrophy vs. Matched non-SMA patients was evaluated on Total healthcare costs (infantile cohort) (Cost ratio 54.2, 95% CI 27.2-107.9, p=<0.001). Infantile-onset spinal muscular atrophy was associated with 54.2 times higher total healthcare costs compared to matched non-SMA controls, averaging $25,517 per month.
Synapse has enriched 10 related papers. Consider them for comparative context: